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Mutations in human collagen VI genes cause a spectrum of musculoskeletal conditions
in children and adults collectively termed collagen VI-related myopathies (COL6-RM)
characterized by a varying degree of muscle weakness and joint contractures and
which include Ullrich Congenital Muscular Dystrophy (UCMD) and Bethlem Myopathy
(BM). Given that collagen VI is one of the most abundant extracellular matrix proteins
in adipose tissue and its emerging role in energy metabolism we hypothesized that
collagen VI deficiency might be associated with alterations in adipose tissue distribution
and adipokines serum profile. We analyzed body composition by means of dual-
energy X-ray absorptiometry in 30 pediatric and adult COL6-RM myopathy patients
representing a range of severities (UCMD, intermediate-COL6-RM, and BM). We found
a distinctive pattern of regional adipose tissue accumulation which was more evident
in children at the most severe end of the spectrum. In particular, the accumulation of
fat in the android region was a distinguishing feature of UCMD patients. In parallel,
there was a decrease in lean mass compatible with a state of sarcopenia, particularly in
ambulant children with an intermediate phenotype. All children and adult patients that
were sarcopenic were also obese. These changes were significantly more pronounced
in children with collagen VI deficiency than in children with Duchenne Muscular
Dystrophy of the same ambulatory status. High molecular weight adiponectin and leptin
were significantly increased in sera from children in the intermediate and BM group.
Correlation analysis showed that the parameters of fat mass were negatively associated
with motor function according to several validated outcome measures. In contrast, lean
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mass parameters correlated positively with physical performance and quality of life.
Leptin and adiponectin circulating levels correlated positively with fat mass parameters
and negatively with lean mass and thus may be relevant to the disease pathogenesis
and as circulating markers. Taken together our results indicate that COL6-RM are
characterized by specific changes in total fat mass and distribution which associate with
disease severity, motor function, and quality of life and which are clinically meaningful
and thus should be taken into consideration in the management of these patients.
Keywords: myopathy, collagen VI, body composition, sarcopenia, obesity, adiponectin, leptin, physical ability
INTRODUCTION
COL6-related myopathies (COL6-RM) are caused by mutations
in COL6A genes (COL6A1, COL6A2, and COL6A3) and
biochemical defects in collagen VI. They represent a
continuum of clinical phenotypes from early severe forms
(Ullrich Congenital Muscular Dystrophy, UCMD) to milder
presentations (Bethlem Myopathy, BM) and intermediate
phenotypes (Cruz et al., 2016). Collagen VI is an ubiquitously
expressed extracellular matrix protein which is particularly
abundant in adipose tissue where it increases with adipogenesis
and localizes surrounding the adipocyte (Nakajima et al.,
2002; Khan et al., 2009; Pasarica et al., 2009). Furthermore,
the expression of collagen VI genes is regulated positively by
glucose levels and negatively by PPAR-γ agonists and leptin
(Muona et al., 1993; Khan et al., 2009; Dankel et al., 2014;
McCulloch et al., 2015). There is increasing evidence that
collagen VI is an important regulator of adipose tissue function
and several recent studies have described the implication of
collagen VI in the metabolic context. For example, COL6A3
mRNA levels are associated with insulin-resistance (Spencer
et al., 2010; Dankel et al., 2014) and obesity in mice and
humans (Khan et al., 2009; McCulloch et al., 2014). In
line with this, lack of collagen VI has been related to a
reduction of fat accumulation and improvement in insulin
sensitivity and glucose clearance in obese mice (Khan et al.,
2009).
Our hypothesis was that collagen VI deficiency, in addition
to a loss of muscle mass, is characterized with changes in the
total amount and distribution of adipose tissue. These changes
are likely to contribute to the deterioration of motor abilities
and quality of life and may predispose patients to metabolic
complications and other health issues. Increased fat mass and
alterations in the distribution of adipose tissue as well as low
muscle mass represent a health risk factor for metabolic and
cardiovascular diseases such as diabetes (Franks et al., 2010;
Burrows et al., 2017).
Despite being considered only a storage tissue, adipose tissue
is an endocrine organ able to synthesize and release signaling
molecules called adipokines such adiponectin, leptin, and retinol
binding protein 4 (RBP4) (Antuna-Puente et al., 2008).
Adiponectin is an adipokine highly present in blood relative
to other adipose tissue hormones. It is directly correlated with
insulin sensibility through its action regulating glucose levels and
lipid oxidation (Shehzad et al., 2012; Caselli, 2014).
On the other hand, leptin levels are directly correlated with
adiposity (Oral and Chan, 2010) and play an important role in
satiety, affecting food intake and metabolism (Kotnik et al., 2015).
Recent studies report that leptin levels regulate the expression of
collagen VI α3 chain (COL6A3) (McCulloch et al., 2014).
Similarly, retinol binding protein-4 (RBP4) is an adipocyte-
derived hormone which contributes to pathogenesis of type 2
diabetes and had been shown to be elevated in insulin-resistance
both in mouse models and humans (Yang et al., 2005).
Previous gene expression studies from our laboratory (Paco
et al., 2013) showed that several adipokines were over-expressed
in UCMD muscle relative to control muscle, in particular, the
genes encoding for adiponectin (9.6-fold change), leptin (5.1-
fold change), and RBP4 (19.6-fold change) which were amongst
the most over-expressed genes. However, the circulating levels of
these hormones in patients with collagen VI related myopathies
has not been investigated.
The aim of the present study was to analyze changes in total
amount and regional distribution of fat and lean tissue using
dual-energy X-ray absorptiometry (DXA) in a population of
pediatric and adult COL6-RM myopathy patients representing
a range of severities and to correlate the findings with various
clinical parameters and with circulating levels of adipokines.
MATERIALS AND METHODS
Ethics Statement
This study was carried out in accordance with the
recommendations of the Hospital Sant Joan de Déu Ethics
Committee. Written informed consent was obtained from
patients and/or their parents or guardians in accordance with
the Declaration of Helsinki. The protocol was approved by the
Hospital Sant Joan de Déu Ethics Committee.
Serum samples were stored in the Biobank of the Hospital Sant
Joan de Déu.
Patients
A total of 30 patients with COL6-RM were included in the study.
They were seen at the Hospital Sant Joan de Déu, Hospital de la
Santa Creu i Sant Pau, and Hospital de Bellvitge in Barcelona.
Patients were diagnosed by clinical exam and medical history
and analysis of collagen VI in muscle biopsy and/or dermal
fibroblasts. In all patients diagnosis was confirmed at the genetic
level.
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Patients were grouped according to clinical criteria as
previously described (Nadeau et al., 2009; Foley et al., 2013;
Deconinck et al., 2014; Meilleur et al., 2014; Cruz et al., 2016).
Early onset/severe (UCMD): Those patients that never
achieved ambulation or lost ambulation before the age of 10
(n = 6). Mean age was 8.6 years at the time of study (age range
2–17 years), 5 males and 1 female.
Intermediate COL6-RM: children who have achieved
ambulation and are currently walking beyond the age of 10
but cannot run or hop, and/or have developed respiratory
insufficiency and are likely to loose ambulation before the age of
19 (n = 8). Mean age was 10.6 (age range 5–16 years), 5 males
and 3 females. Here, we included three patients aged 5, 6, and 7
at the time of the study who are ambulant [6-min-walking test
(6MWT) above 300 m] but cannot run or jump and are likely to
remain ambulant beyond 10 years of age.
Bethlem Myopathy: Individuals who achieve and maintain
ambulation into adulthood (n = 16). Mean age: 33.1 years (age
range: 11–59 years), 6 males and 10 females. Within this group we
included four teenagers between 11 and 17 years old at the time of
the study who are mildly affected (able to run and have a 6MWT
above 400 m and have not developed respiratory insufficiency).
Body composition parameters in UCMD and intermediate
COL6-RM patients were compared with patients with genetically
confirmed Duchenne Muscular Dystrophy (n = 31, age range
5–18) which were either ambulant (n= 17) or non-ambulant (14)
at the time of DXA analysis.
Body Composition by DXA
Body composition measurements were made by DXA with a
General Electric Healthcare unit, Prodigy model, software version
12.3. Distinctions made in each body region provided an analysis
of the composition in a model of three components: skeletal
mineral content (BMC), fat body mass (FM), and lean body
mass (LM).
For scanning, patients were positioned supine, following the
manufacturer’s recommendations for this type of exploration.
However, the technique had to be adapted to the particular
characteristics of our patients. In all cases total measurements
were estimated on the values of the right half-ibody. Regions
explored in patients were: whole body, upper and lower
extremities, trunk, lower abdominal region of the trunk (limited
by iliac crests and the upper limit of the ribs) and the sector
of the hips, the latter two regions designated android and
gynecoid, respectively. With results of whole-body and regional
measurements the following ratios were calculated: fat mass index
(FMI) [FM/height (Nakajima et al., 2002)] and lean mass index
(LMI) [LM/height (Nakajima et al., 2002)]. Appendicular fat free
mass index (AFFMI) was calculated as the sum of lean mass in
lower extremities and upper extremities/height (Nakajima et al.,
2002). Relationships between the fatty tissue and lean tissue of the
lower extremities and upper extremities, adjusted for the size of
the subject, were calculated.
Appendicular fat free mass index was used to define a state
of sarcopenia when it was below 2 standard deviations from the
mean value observed in the reference population for the same
age and sex (Baumgartner et al., 1998). Sarcopenic obesity was
defined according to Baumgartner et al. (2004) as a decrease
in AFFM of two or more 2 standard deviations accompanied
by increase in fat mass above 27% in male and 40% in female
patients, respectively.
Enzyme-Linked Immunosorbent Assay
Enzyme-linked immunosorbent assay (ELISA) was used
for detection of adiponectin high molecular weight (HMW
adiponectin), leptin and binding retinol protein 4 (RBP4) levels
using commercial ELISA kits #EZHMWA-64K, #EZHL-80SK
(Millipore, Temecula, CA, United States) and DRB400 (R&D
systems, Minneapolis, MN, United States) respectively, in serum
samples of patients which were collected the same day of DXA
analysis. Plates were incubated and treated as described in the
manufacturer’s protocol and then the absorbance was detected
at 450 nm by EMax R© Microplate Reader (Molecular Devices,
Sunnyvale, CA, United States). Values were compared with
the standard curve and concentration of each sample was
determined (ng/mL).
Patient Assessment of Physical
Performance and Quality of Life
As outcome measures of physical performance in ambulant
patients we applied the Motor Function Measure 32 (MFM32),
the North Star Ambulatory Assessment (NSAA), the upper limb
scale (PULL.85), 6MWT, timed function tests (time taken to
rise from floor, run/walk 10 m, climb four standard-sized stairs,
and descend four standard-sized stairs) (McDonald et al., 2013).
For non-ambulant patients we applied the Egen Klassifikation 2
(EK2) and the upper limb scales (PULL.85) since these have been
validated and shown to be feasible and reliable in this group of
patients (Meilleur et al., 2014). The neuromuscular module of
the pediatric quality of life (PedsQL) scale was used to obtain an
indication of patient (and parent) perceived quality of life.
Statistical Analysis
To assess changes in body composition in patients, measurements
of each disease group were compared with those of healthy
Spanish subjects of the same sex and age which were taken as
reference values for each of the variables. These data from healthy
controls (consisting of a total of 1300 individuals between 7 and
80 years old grouped by sex and age) were collected by Dr. Luis
del Río. Body mass index (BMI) of patients under 20 years of age
was compared with WHO database using the “WHO AnthroPlus
Software Manual for Personal Computers: Software for assessing
growth of the world’s children and adolescents. Geneva: WHO,
20091.”
Statistically significant changes for each variable in the disease
population were studied by Z-score which was calculated with
the formula z = (x − µ)/σ; where x represents the value in the
patient; µ is the mean value in the reference population, and σ is
the value of the standard deviation in the reference population.
A change in Z-score value largest than 2 standard deviations was
considered statistically significant. The positive or negative sign
of Z indicated the direction of the deviation.
1http://www.who.int/growthref/tools/en/
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Pearson correlation coefficient was calculated using SPSS
software (SPSS 19.0 (Armonk, NY, United States: IBM Corp)
to investigate associations between each body composition
measurement and the different functional scores, timed-tests, and
adipokines levels.
RESULTS
Body Composition
Body composition measurements were made by DXA. Regions
explored included whole body, upper and lower extremities,
trunk, lower abdominal region of the trunk (android), and the
sector of the hips (gynecoid) (Figure 1).
The FMI (see “Materials and Methods”) was on average
significantly elevated in UCMD and intermediate groups but
normal in BM patients (Figure 2A). In contrast the mean BMI
was within normal limits in all three groups relative to the
Spanish reference population (data not shown). The percentage
of fat in the legs and the amount of fat accumulated in
the gynecoid region were also increased in all three groups
being highest in the more severe patients (UCMD) followed by
intermediate and then BM patients (Figures 2B,C). The amount
of fat in the trunk was elevated in UCMD and intermediate
patients (Figure 2D) whereas the amount of fat in the android
region was elevated in UCMD patients only (Figure 2E). Within
the intermediate group, Z-scores were significantly higher in
female patients than in their male counterparts. We could not
analyze sex differences in UCMD patients since there was only
one female patient. There were no significant sex differences in
BM patients.
The LMI was significantly reduced in UCMD and
intermediate groups but not in the BM group whereas the
AFFMI was significantly reduced in all three groups. For
both parameters the lowest Z-score was found in intermediate
patients (Figures 3A,B). There were no significant sex differences
regarding these lean mass parameters (data not shown).
Appendicular fat free mass index is used as an indicator
of sarcopenia which is a condition characterized by loss of
muscle mass and either low muscular strength or low physical
performance (Cruz-Jentoft et al., 2010).
Sarcopenia has been previously used to describe the extent of
decline of muscle mass in patients with various forms of muscular
dystrophy and in adults with COL6-RM (Miscione et al., 2013;
Merlini et al., 2014). According to established criteria (AFFMI
below a Z-score of 2), (Baumgartner et al., 2004) 66% of UCMD
patients, 100% of intermediate COL6-RM patients, and 62% of
BM patients were sarcopenic.
All patients (children and adult) except one BM patient
(who was not sarcopenic) had an overall percentage of fat mass
above the obesity threshold (28% for women and 40% for men)
(Figure 4). Therefore, all sarcopenic patients were also obese as
previously described in adults with COL6-RM (Miscione et al.,
2013).
To investigate the effect of ambulation in the observed changes
we compared the body composition of children in the UCMD
(all non-ambulant) and intermediate (all ambulant) groups with
FIGURE 1 | Representative dual-energy X-ray absorptiometry (DXA) scan
showing the soft tissues in the different regions analyzed for one of the
children with Ullrich Congenital Muscular Dystrophy (UCMD), Top, and an
adult patient with Bethlem Myopathy (BM), Bottom, and their corresponding
clinical images. Written informed consent was obtained for the publication of
this image.
those of ambulant (n = 17) and non-ambulant DMD (n = 14)
children, respectively, within the same age range. Although both
forms of muscular dystrophy are different in many respects (age
of onset, pattern of weakness, etc.) both lead to early loss of
ambulation and a decline in muscle mass and function (Merlini
et al., 2014).
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FIGURE 2 | Changes in amount of fat mass by DXA in UCMD, intermediate phenotype and BM patients in whole body normalized to height squared (fat mass index,
FMI) (A), gynecoid region (B), legs (C), trunk (D), and android region (E). Results are expressed as mean on Z-score for each group. Threshold of significance was
considered when Z-score ≥ 2 or Z-score ≤ –2 and was indicated with dotted line. #P ≤ 0.05.
FIGURE 3 | Changes in amount of lean mass by DXA in UCMD, intermediate phenotype and BM patients in whole body normalized to height squared (lean mass
index, LMI) (A) and appendicular free fat mass normalized to height squared (AFFMI) (B). Results are expressed as mean on Z-score for each group. Threshold of
significance was considered when Z-score ≥ 2 or Z-score ≤ –2 and was indicated with dotted line. #P ≤ 0.05 and ###P ≤ 0.001.
FIGURE 4 | Representation of the percentage of body fat mass in UCMD, intermediate phenotype and BM patients divided by sex. The percentage of body fat mass
of each patient was calculated as the ratio between the value of the total amount of body fat mass and the weight of the patient. The value obtained was multiplied
by 100. Dotted lines indicate obesity threshold based on Baumgartner (2000) (>27% for men and >40% in women).
We observed that FMI, fat mass in the trunk and android
regions were normal in both ambulant and non-ambulant DMD
patients whereas the percentage of fat in the legs and the amount
of fat in the gynecoid regions were significantly elevated in non-
ambulant DMD (Z-score > 2) (Figure 5) relative to the reference
population.
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FIGURE 5 | Changes in amount of fat mass by DXA in UCMD, intermediate phenotype and DMD ambulant and non-ambulant patients in whole body normalized to
height squared (FMI) (A), gynecoid region (B), legs (C), trunk (D), and android region (E). Results are expressed as mean on Z-score for each group. Threshold of
significance was considered when Z-score ≥ 2 or Z-score ≤ –2 and was indicated with dotted line. #P ≤ 0.05, ##P ≤ 0.01, and ###P ≤ 0.001.
FIGURE 6 | Changes in amount of lean mass by DXA in UCMD, intermediate phenotype and DMD ambulant and non-ambulant patients in whole body normalized
to height squared LMI (A) and appendicular free fat mass normalized to height squared (AFFMI) (B). Results are expressed as mean on Z-score for each group.
Threshold of significance was considered when Z-score ≥ 2 or Z-score ≤ –2 and was indicated with dotted line. #P ≤ 0.05, ##P ≤ 0.01, and ###P ≤ 0.001.
The FMI, fat in the trunk and android fat were significantly
higher in UCMD (non-ambulant patients) than in non-ambulant
DMD patients. All fat parameters were significantly higher
in intermediate COL6-RM patients than in ambulant DMD
children (Figure 5).
With regards to lean mass, the LMI and AFFMI were normal
in ambulant DMD children and reduced in non-ambulant DMD
children relative to the reference population (Figure 6).
The LMI and the AFMMI were significantly lower in
intermediate COL-6 RM patients than in ambulant DMD
patients (and in non-ambulant DMD vs. ambulant DMD
children) (Figure 6). However, there were no significant
differences between UCMD and non-ambulant DMD groups.
Adipokines Profile
Serum leptin, HMW adiponectin and RBP4 were analyzed by
ELISA in sera from UCMD (n = 4), intermediate COL6-RM
(n = 6), and BM patients (n = 6) and compared with either
pediatric controls (n = 19) or adult controls (n = 6) and with
DMD children as a disease control group (n = 10). We found
a significant increase of serum adiponectin and leptin levels in
patients within the intermediate and milder BM phenotype but
not in the more severe UCMD patients. In contrast, adiponectin
HMW was significantly reduced in DMD children (Figure 7).
We did not observe any significant change in RBP4 in any of the
groups analyzed.
Correlation Analysis with Physical Ability
and Quality of Life
We then looked for possible associations between the various
parameters analyzed. A correlation was considered large if
r > 0.65, medium if r between 0.5 and 0.65, and small when r
is below 0.5.
In non-ambulant UCMD patients the largest and significant
correlations were found between the fat mass parameters and the
EK2 score (the lower the better physical performance) as well as
with the PUL score (the higher the better performance) (Table 1).
Surprisingly, in both cases the higher the value of the fat indices
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FIGURE 7 | High molecular weight Adiponectin serum levels in UCMD and intermediated phenotype patients relative to controls and DMD patients (A) and in BM
patients relative to adult controls (B). Leptin serum levels in UCMD and intermediated phenotype patients relative to controls and DMD patients (C) and in BM
patients relative to adult controls (D). Serum samples were analyzed by ELISA technique. Adipokine levels are expressed as mean ± SEM for each group of patients.
∗P ≤ 0.05 and ∗∗P ≤ 0.01 relative to controls and #P ≤ 0.05 and ###P ≤ 0.001 relative to intermediated phenotype.
the better the performance. The LMI showed a strong correlation
with the PUL score. There was also a positive correlation between
fat mass indices and the score for the quality of life questionnaire
(the higher the worse self-perception of quality of life).
In the intermediate group (Table 2) strong and significant
correlations were found between the percentage of fat in legs,
android, and gynecoid regions and the time to run 10 m. The
amount of fat in the trunk correlated negatively and significantly
with the PUL score. There was a large and significant correlation
between the LMI and the NSAA and MFM32 scores. In contrast,
the AFFMI did not show any large correlation with any of the
body composition parameters in this group of patients.
The quality of life questionnaire score showed a positive and
significant correlation with the Z-score of the fat in the trunk (in
children and parents).
In the BM group the percentage of fat mass in legs correlated
negatively with the 6MWT and the MFM and NSAA scores
and positively with the time to walk/run 10 m and the time to
raise from the floor, although none of these reached statistical
significance (Table 3). There was a strong and significant negative
TABLE 1 | Correlations in Ullrich Congenital Muscular Dystrophy (UCMD) patients expressed as values of Pearson’s correlation coefficient (r) between variables of body
composition expressed in Z-score (lines) and variables of motor function, quality of life or adipokine levels (columns).
EK2 PULL Peds QL Peds QL Parents Leptin HMW adiponectin
FMI −0.83∗ 0.77 0.72 0.73 0.57 0.73
Fat mass trunk −0.88∗ 0.78 0.67 0.54 0.5 0.66
Android −0.69 0.54 0.44 0.67 0.29 0.95
% Fat mass legs −0.86∗ 0.4 0.99 0.64 0.46 0.87
Gynecoid −0.73 −0.45 0.33 0.01 0.63 0.76
LMI 0.55 0.86 0.57 −0.12 −0.62 −0.66
AFFMI 0.32 0.35 0.52 0.25 −0.04 −1.00∗∗
Statistical significance was tested with two-tailed t student ∗P ≤ 0.05 and ∗∗P ≤ 0.001.
Frontiers in Aging Neuroscience | www.frontiersin.org 7 August 2017 | Volume 9 | Article 268
fnagi-09-00268 August 5, 2017 Time: 13:26 # 8
Rodríguez et al. Body Composition in Collagen VI Deficiency
correlation between the amount of fat in the android region and
the MFM score.
There were several large and significant correlations between
the body composition parameters and the circulating levels of
leptin and adiponectin. In the UCMD group, levels of HMW
adiponectin correlated positively with the indices of fat mass and
negatively with the amount of lean mass (in particular with the
AFFMI). A similar tendency was observed in the other groups
(Tables 1–3).
DISCUSSION
Herein we report a detailed description of changes in body
composition by means of DXA in children with COL6-RM and
how they relate to physical performance.
We found a significant increase in total body fat mass and/or
in the amount of fat in specific body regions which depended on
severity of the phenotype.
All fat mass parameters were higher in the most severe UCMD
patients than in patients with the intermediate phenotype and
patients with BM. The amount of fat in the android region was
increased in UCMD patients whereas it was comparable to the
reference population in patients with the intermediate phenotype
(although differences between both groups were not significant).
Furthermore there was a statistically significant difference in the
amount of fat in the trunk and legs between UCMD and BM
patients.
Our results suggest that in COL6-RM children, the increased
adiposity cannot be ascribed solely to the ambulatory status.
When we analyzed body composition in DMD patients the results
were clearly different. In non-ambulant DMD patients four out
of the five fat mass parameters analyzed were normal or only
marginally increased and in ambulant DMD patients none of
the fat mass parameters were elevated in comparison with the
reference population and in contrast to children with collagen VI
deficiency.
Furthermore, all indices of adiposity were higher in
UCMD patients than in non-ambulant DMD patients and
in intermediate COL6-RM patients than in ambulant DMD
children. The difference between UCMD patients and non-
ambulant DMD children was statistically significant for the
central regions (trunk and android) suggesting that these body
areas are more prone to fat accumulation in association with
collagen VI defects.
The deviation from normal of the total lean mass was
larger in UCMD and intermediate phenotype patients than the
deviation of the lean mass in the extremities probably reflecting
the predominant involvement of axial and abdominal muscles.
In contrast the LMI was normal in BM patients whereas the
AFFMI was mildly reduced. In both cases the Z-scores were
lower in patients within the intermediate category (ambulant)
than in patients with UCMD (non-ambulant). This suggests that
pathways triggered by physical activity may determine the extent
of muscle loss. On the other hand, the loss of muscle mass in the
most severe UCMD patients (even in the youngest patients who
TABLE 2 | Correlations in intermediate phenotype patients expressed as values of Pearson’s correlation coefficient (r) between variables of body composition expressed
in Z-score (lines) and variables of motor function, quality of life or adipokine levels (columns).
6MWT Raise from
floor
Climb up
4 stairs
Climb down
4 stairs
10 m MFM NSAA PUL PedsQL PedsQL
parents
Leptin HMW
adiponectin
FMI −0.36 −0.17 0.68 0.64 0.68 −0.26 −0.26 0.01 0.31 0.09 0.56 0.49
Fat mass trunk −0.11 0.83 0.14 0.12 0.26 −0.36 −0.39 −0.96∗ 0.78∗ 0.75∗ 0.62 0.48
Android −0.41 0.36 0.67 0.63 0.78∗ −0.47 −0.54 −0.29 0.48 0.33 0.8 0.29
% Fat Mass Legs −0.52 −0.1 0.7 0.67 0.82∗ −0.35 −0.4 −0.13 0.42 0.25 0.64 0.31
Gynecoid −0.56 0.33 0.78∗ 0.75 0.86∗ −0.56 −0.62 −0.29 0.53 0.36 0.75 0.25
LMI 0.55 −0.59 −0.49 −0.5 −0.54 0.91∗ 0.84∗ 0.48 −0.46 −0.53 −0.2 0.64
AFFMI 0.29 −0.21 0.05 −0.01 0.1 0.32 0.26 0.02 −0.04 −0.11 0.54 0.4
Statistical significance was tested with two-tailed t student ∗P ≤ 0.05.
TABLE 3 | Correlations in BM patients expressed as values of Pearson’s correlation coefficient (r) between variables of body composition expressed in Z-score (lines) and
variables of motor function, quality of life or adipokine levels (columns).
6MWT Raise from
floor
Climb up
4 stairs
Climb down
4 stairs
10 m MFM NSAA PUL PedsQL PedsQL
parents
Leptin HMW
adiponectin
FMI −0.30 0.78 0.45 0.32 0.48 −0.53 −0.19 −0.15 −0.17 0.98 0.51 0.37
Fat mass trunk −0.01 0.73 0.10 0.09 0.29 −0.60 −0.46 0.28 −0.51 0.69 0.24 −0.03
Android −0.55 0.77 0.48 0.51 0.65 −0.82∗ −0.69 −0.12 −0.06 0.99 0.63 0.23
% Fat mass legs −0.67 0.71 0.53 0.55 0.67 −0.77 −0.74 −0.25 0.02 0.78 0.56 0.35
Gynecoid −0.38 0.71 0.48 0.38 0.52 −0.55 −0.21 −0.28 −0.06 0.72 0.65 0.41
LMI 0.40 −0.24 −0.64 −0.48 −0.54 0.02 −0.33 0.65 −0.17 0.01 −0.63 −0.24
AFFMI 0.15 −0.25 −0.56 −0.34 −0.41 −0.12 −0.53 0.56 −0.12 −0.17 −0.77 −0.14
Statistical significance was tested with two-tailed t student ∗P ≤ 0.05.
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never walked) indicates that it is a feature inherent to the disease
in line with the observed muscle fiber atrophy that we and others
have described in muscle biopsies of very young patients (Schessl
et al., 2008; Paco et al., 2012).
The LMI and AFFMI were normal in ambulant DMD children
and reduced in non-ambulant DMD children relative to the
reference population. This is in agreement with previous findings
of significantly lower mean mass in non-ambulant adult muscular
dystrophy patients than in ambulant ones (Merlini et al., 2014).
Furthermore, the LMI and the AFMMI were significantly lower
in intermediate patients than in ambulant DMD patients (and in
non-ambulant DMD versus ambulant DMD children).
These observations suggest that in dystrophin deficiency the
loss of muscle mass is associated with loss of ambulation whereas
in UCMD this is not the case.
In all three groups of patients sarcopenia co-existed with
obesity as previously described in adult patients (Merlini et al.,
2014). Also, similar to what other authors have reported, there
was no deviation from normal in the mean BMI which may be
explained by the loss of muscle mass and the fatty infiltration
of skeletal muscle (Toni et al., 2014) and which highlights the
usefulness of the determination of total fat mass by DXA.
There was a clear association between various indices of fat
mass and physical performance. In particular, within the group of
patients with the intermediate phenotype the correlation analysis
showed several informative associations. This may be partly due
to the wider breadth of tests of physical performance that can be
applied in this group of patients compared to the non-ambulant
UCMD group. In particular, the amount of fat accumulated in the
android, gynecoid regions, and legs were very good indicators of
worse physical performance in particular when using the 10 m
test. In contrast, the overall lean mass (LMI) correlated strongly
and significantly with the NSAA and MFM scores. The fat mass
in the central body region (trunk) showed a very strong and
significant association with the quality of life as perceived by the
patients and their parents (the higher the amount of fat the worse
quality of life score).
Thus, these observations suggest that body composition
parameters as measured by DXA can be used as quantitative
and objective markers of physical performance although further
validation in larger cohorts is required. These results can also help
toward selecting the most appropriate outcome measures in each
subgroup of patients according to their severity for a more refined
analysis of COL6-RM.
There are two other studies looking at body composition by
DXA in patients with collagen VI deficiency although both look
at the same cohort composed of one adult UCMD and seven adult
BM patients (Miscione et al., 2013; Toni et al., 2014). In those
studies they use as the reference population a cohort of healthy
individuals from the United States (Kelly et al., 2009). In our
study, we have used as a reference a Spanish healthy population
removing thus variability due to differences in diet and lifestyle
between different populations/countries. Finally, in our study we
provide additional data on regional fat accumulation.
Our previous microarray data demonstrated an increase in
the mRNA levels of the main adipokines secreted by adipose
cells (leptin, adiponectin, and RBP4) in skeletal muscle biopsies
in UCMD patients (Paco et al., 2013). To investigate if this
translated into a systemic increase in protein levels we measured
serum levels of the three hormones in sera from patients by
ELISA. However, the number of patients in each subgroup for
which we had serum samples was small and thus results need to
be confirmed.
Determination of serum adipokines showed a significant
increase of HMW adiponectin and leptin levels in patients in the
intermediate and BM categories. In contrast, HWM adiponectin
in DMD patients showed a significant reduction as described in
mouse models (Hathout et al., 2014; Abou-Samra et al., 2015).
In obesity, the accumulation of fat leads to a dysregulation
of adipokines and decreased circulating levels of adiponectin
(Asayama et al., 2003; Kern et al., 2003). In contrast, in this study
we observed an increase in HMW adiponectin levels despite
the evidence of increased adiposity in the patient cohort. This
increase was, however, not significant in the UCMD group which
showed the highest degree of body fat. Moreover, circulating
HMW adiponectin showed a very strong and consistent positive
association with the amount of fat (global and regional)
and a negative relationship with the lean mass (global and
appendicular).
These observations may indicate that in patients with
mutations in collagen VI genes there is another mechanism,
independent of the increase in fat mass, which is mediating
the increase of circulating adiponectin and perhaps the over-
expression of adiponectin gene in muscle that we described (Paco
et al., 2013). One may also speculate that patients at the most
severe end of the spectrum undergo a reduction in adiponectin
similarly to obese patients without collagen VI mutations and
that is why their levels were not significantly reduced relative to
the control group.
Adiponectin is a hormone strongly related with the regulation
of glucose and lipid metabolism in insulin sensitive organs,
included skeletal muscle (Caselli, 2014). The decrease in muscle
mass in combination with increased adipose tissue described here
may be interfering with correct adiponectin-mediated signaling
in different steps including adiponectin synthesis, release or
receptor sensitivity. According to our results adiponectin
circulating levels may represent a valuable indicator of muscle
mass loss, however, role of adipokines in the pathophysiology of
collagen VI myopathies needs to be further investigated.
In summary, our results show that collagen VI related
myopathies are associated with obesity and other alterations in
fat tissue mass and distribution and adipokines profile. These
should be taken into account in the management of these patients
since they represent a risk factor for metabolic and cardiovascular
complications. We propose that endocrinological assessment
is performed as part of the routine follow up of patients
with collagen VI deficiency for early detection of metabolic
complications and so that appropriate measures such as dietary
control can be applied. Analysis of body composition by DXA is
a sensitive and feasible technique to assess the increase in body
fat mass and the loss of muscle tissue and as our results show as a
quantitative and objective marker of physical performance which
could complement other outcome measures to monitor clinical
progression and efficacy of therapeutic interventions.
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